Crossmark

A phase II, open-label clinical trial on the combination therapy with medium-chain triglycerides and ghrelin in patients with chronic obstructive pulmonary disease

Crossref DOI link: https://doi.org/10.1007/s12576-019-00716-2

Published Print: 2019-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Miki, Keisuke https://orcid.org/0000-0002-5351-8319
Kitada, Seigo

Miki, Mari

Hui, Shu-Ping

Shrestha, Rojeet

Yoshimura, Kenji

Tsujino, Kazuyuki

Kagawa, Hiroyuki

Oshitani, Yohei

Kida, Hiroshi

Maekura, Ryoji

Kangawa, Kenji
Funding

Funding for this research was provided by:

Intramural Research Fund (25-3-1)

Grant-in-Aid for Clinical Research from the National Hospital Organization
License Information

Text and Data Mining valid from 2019-11-01

Text and Data Mining valid from 2019-11-01

Version of Record valid from 2025-01-01
More Information

This article is maintained by: Elsevier

Article Title: A phase II, open-label clinical trial on the combination therapy with medium-chain triglycerides and ghrelin in patients with chronic obstructive pulmonary disease

Journal Title: The Journal of Physiological Sciences

CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s12576-019-00716-2

Content Type: article

Copyright: Copyright © 2019 The Physiological Society of Japan and Springer Japan KK, part of Springer Nature. Published by Elsevier Inc.

Document is current

Any future updates will be listed below